Kaydan Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$433K Buy
2,978
+53
+2% +$7.32K 0.15% 71
2026
Q2
$376K Hold
2,925
– – 0.11% 83
2026
Q1
$352K Sell
2,925
-2
-0.1% -$231 0.12% 79
2025
Q4
$308K Hold
2,927
– – 0.09% 85
2025
Q3
$246K Buy
2,927
+19
+0.7% +$1.56K 0.07% 100
2025
Q2
$230K Hold
2,908
– – 0.08% 100
2025
Q1
$261K Hold
2,908
– – 0.08% 91
2024
Q4
$289K Hold
2,908
– – 0.1% 85
2024
Q3
$330K Buy
+2,908
New +$345K 0.1% 83

Other funds holding MRK

Kaydan Wealth Management's MRK Position: Q3 2026 in Review

Kaydan Wealth Management increased its Merck (MRK) stake by 1.8% in Q3 2026, buying an estimated $7.32K and bringing the position to 2,978 shares worth $433K. The position accounts for 0.15% of the portfolio, ranked #71.

Kaydan Wealth Management first reported a position in MRK in Q3 2024 and has held it in 9 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Kaydan Wealth Management held 2,978 shares of Merck worth $433K as of Q3 2026.
  • Kaydan Wealth Management bought 53 Merck shares in Q3 2026, an estimated $7.32K.
  • Merck made up 0.15% of Kaydan Wealth Management's portfolio in Q3 2026, its #71 holding.
  • Kaydan Wealth Management first reported a position in Merck in Q3 2024 and has held it in 9 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Kaydan Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.